Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 180

Similar articles for PubMed (Select 16988018)

1.

Culture-independent analyses of temporal variation of the dominant fecal microbiota and targeted bacterial subgroups in Crohn's disease.

Scanlan PD, Shanahan F, O'Mahony C, Marchesi JR.

J Clin Microbiol. 2006 Nov;44(11):3980-8. Epub 2006 Sep 20. Erratum in: J Clin Microbiol. 2007 May;45(5):1671.

2.

Changes of faecal microbiota in patients with Crohn's disease treated with an elemental diet and total parenteral nutrition.

Shiga H, Kajiura T, Shinozaki J, Takagi S, Kinouchi Y, Takahashi S, Negoro K, Endo K, Kakuta Y, Suzuki M, Shimosegawa T.

Dig Liver Dis. 2012 Sep;44(9):736-42. doi: 10.1016/j.dld.2012.04.014. Epub 2012 May 22.

PMID:
22622202
3.

Molecular characterisation of the faecal microbiota in patients with type II diabetes.

Wu X, Ma C, Han L, Nawaz M, Gao F, Zhang X, Yu P, Zhao C, Li L, Zhou A, Wang J, Moore JE, Millar BC, Xu J.

Curr Microbiol. 2010 Jul;61(1):69-78. doi: 10.1007/s00284-010-9582-9. Epub 2010 Jan 20.

PMID:
20087741
4.

Multicenter analysis of fecal microbiota profiles in Japanese patients with Crohn's disease.

Andoh A, Kuzuoka H, Tsujikawa T, Nakamura S, Hirai F, Suzuki Y, Matsui T, Fujiyama Y, Matsumoto T.

J Gastroenterol. 2012 Dec;47(12):1298-307. doi: 10.1007/s00535-012-0605-0. Epub 2012 May 11.

PMID:
22576027
5.

Clostridium leptum group bacteria abundance and diversity in the fecal microbiota of patients with inflammatory bowel disease: a case-control study in India.

Kabeerdoss J, Sankaran V, Pugazhendhi S, Ramakrishna BS.

BMC Gastroenterol. 2013 Jan 26;13:20. doi: 10.1186/1471-230X-13-20.

6.

Temporal stability analysis of the microbiota in human feces by denaturing gradient gel electrophoresis using universal and group-specific 16S rRNA gene primers.

Vanhoutte T, Huys G, Brandt E, Swings J.

FEMS Microbiol Ecol. 2004 Jun 1;48(3):437-46. doi: 10.1016/j.femsec.2004.03.001.

7.

Molecular analysis of the gut microbiota of identical twins with Crohn's disease.

Dicksved J, Halfvarson J, Rosenquist M, Järnerot G, Tysk C, Apajalahti J, Engstrand L, Jansson JK.

ISME J. 2008 Jul;2(7):716-27. doi: 10.1038/ismej.2008.37. Epub 2008 Apr 10.

PMID:
18401439
8.

Genetic diversity of viable, injured, and dead fecal bacteria assessed by fluorescence-activated cell sorting and 16S rRNA gene analysis.

Ben-Amor K, Heilig H, Smidt H, Vaughan EE, Abee T, de Vos WM.

Appl Environ Microbiol. 2005 Aug;71(8):4679-89.

9.

Alterations of the dominant faecal bacterial groups in patients with Crohn's disease of the colon.

Seksik P, Rigottier-Gois L, Gramet G, Sutren M, Pochart P, Marteau P, Jian R, Doré J.

Gut. 2003 Feb;52(2):237-42.

10.

The biodiversity and composition of the dominant fecal microbiota in patients with inflammatory bowel disease.

Sha S, Xu B, Wang X, Zhang Y, Wang H, Kong X, Zhu H, Wu K.

Diagn Microbiol Infect Dis. 2013 Mar;75(3):245-51. doi: 10.1016/j.diagmicrobio.2012.11.022. Epub 2012 Dec 28.

PMID:
23276768
11.

Ethnic diversity of gut microbiota: species characterization of Bacteroides fragilis group and genus Bifidobacterium in healthy Belgian adults, and comparison with data from Japanese subjects.

Ishikawa E, Matsuki T, Kubota H, Makino H, Sakai T, Oishi K, Kushiro A, Fujimoto J, Watanabe K, Watanuki M, Tanaka R.

J Biosci Bioeng. 2013 Aug;116(2):265-70. doi: 10.1016/j.jbiosc.2013.02.010. Epub 2013 Mar 21.

PMID:
23522670
12.

Molecular monitoring of the fecal microbiota of healthy human subjects during administration of lactulose and Saccharomyces boulardii.

Vanhoutte T, De Preter V, De Brandt E, Verbeke K, Swings J, Huys G.

Appl Environ Microbiol. 2006 Sep;72(9):5990-7.

13.

Fecal Microbiota in Pediatric Inflammatory Bowel Disease and Its Relation to Inflammation.

Kolho KL, Korpela K, Jaakkola T, Pichai MV, Zoetendal EG, Salonen A, de Vos WM.

Am J Gastroenterol. 2015 Jun;110(6):921-30. doi: 10.1038/ajg.2015.149. Epub 2015 May 19.

PMID:
25986361
14.

Specificities of the fecal microbiota in inflammatory bowel disease.

Sokol H, Seksik P, Rigottier-Gois L, Lay C, Lepage P, Podglajen I, Marteau P, Doré J.

Inflamm Bowel Dis. 2006 Feb;12(2):106-11.

PMID:
16432374
15.

Biodiversity of the mucosa-associated microbiota is stable along the distal digestive tract in healthy individuals and patients with IBD.

Lepage P, Seksik P, Sutren M, de la Cochetière MF, Jian R, Marteau P, Doré J.

Inflamm Bowel Dis. 2005 May;11(5):473-80.

PMID:
15867587
16.

Terminal restriction fragment length polymorphism analysis of the gut microbiota profiles of pediatric patients with inflammatory bowel disease.

Aomatsu T, Imaeda H, Fujimoto T, Takahashi K, Yoden A, Tamai H, Fujiyama Y, Andoh A.

Digestion. 2012;86(2):129-35. doi: 10.1159/000339777. Epub 2012 Jul 27.

PMID:
22846404
17.

Molecular characterization of fecal microbiota in patients with viral diarrhea.

Ma C, Wu X, Nawaz M, Li J, Yu P, Moore JE, Xu J.

Curr Microbiol. 2011 Sep;63(3):259-66. doi: 10.1007/s00284-011-9972-7. Epub 2011 Jul 8.

PMID:
21739252
18.

The bacteriology of biopsies differs between newly diagnosed, untreated, Crohn's disease and ulcerative colitis patients.

Bibiloni R, Mangold M, Madsen KL, Fedorak RN, Tannock GW.

J Med Microbiol. 2006 Aug;55(Pt 8):1141-9.

PMID:
16849736
19.

Imbalance in intestinal microflora constitution could be involved in the pathogenesis of inflammatory bowel disease.

Takaishi H, Matsuki T, Nakazawa A, Takada T, Kado S, Asahara T, Kamada N, Sakuraba A, Yajima T, Higuchi H, Inoue N, Ogata H, Iwao Y, Nomoto K, Tanaka R, Hibi T.

Int J Med Microbiol. 2008 Jul;298(5-6):463-72. Epub 2007 Sep 25.

PMID:
17897884
20.

Cross-sectional and longitudinal comparisons of the predominant fecal microbiota compositions of a group of pediatric patients with cystic fibrosis and their healthy siblings.

Duytschaever G, Huys G, Bekaert M, Boulanger L, De Boeck K, Vandamme P.

Appl Environ Microbiol. 2011 Nov;77(22):8015-24. doi: 10.1128/AEM.05933-11. Epub 2011 Sep 16.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk